FMR LLC 13D and 13G filings for Neumora Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:36 am Sale | 2025-03-31 | 13G | NEUMORA THERAPEUTICS INC NMRA | FMR LLC | 3,496,316 2.200% | -5,126,152 (-59.45%) | Filing |
| 2024-07-08 4:15 pm Unchanged | 2024-06-28 | 13G | NEUMORA THERAPEUTICS INC NMRA | FMR LLC | 8,622,468 5.400% | 0 (Unchanged) | Filing |
| 2024-07-08 1:07 pm Purchase | 2024-06-28 | 13G | NEUMORA THERAPEUTICS INC NMRA | FMR LLC | 8,622,468 5.400% | 8,622,468 (New Position) | Filing |